Is everyone taking too much magnesium? We analyze the supplement hype, the real science, and the industry agenda behind the mineral craze.
The booming market for beauty supplements is built on shaky science. We dissect the latest research on 'nutricosmetics' and expose who really profits.
Lupin's deal with TTP plc UK isn't just about better inhalers; it’s a desperate play in the high-stakes **pharmaceutical technology** sector.
Dermatologists are quietly admitting that ingestible collagen supplements fail to deliver on their viral beauty promises. We dissect the industry.
The explosive rise of bovine colostrum supplements hides a darker truth about athletic performance and profit margins. Unpacking the science and the skepticism.
Alteogen's subcutaneous injection tech transfer isn't just pharma news; it's a seismic shift in drug delivery, threatening Big Pharma's oral dominance.